Events
TLC announced the upcoming presentation of two scientific abstracts on TLC590 which have been accepted for the 44th Annual Regional Anesthesiology & Acute Pain Medicine Meeting hosted by the American Society of Regional Anesthesia and Pain Medicine.
Winners of Ibtikari program present innovative startups at Angel Rising Investor Education Symposium
The four winners of the Khalifa Fund for Enterprise Development and startAD’s Ibtikari (My Innovation) program, which aims to inspire Emiratis to come up with innovative ideas across various fields, recently presented their projects during Ibtikari Demo Day held in conjunction with Angel Rising Investor Education Symposium at New York University Abu Dhabi.
BioArctic AB announces that its partner Eisai will give poster presentations related to BAN2401 in early Alzheimer’s disease at the 14th International Conference on Alzheimer’s & Parkinson’s Diseases on March 27 in Lisbon, Portugal.
Immunicum AB announced that members of the management team will attend and present at upcoming conferences in March and April.
The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. Furthermore, the Management Board will present an outlook for fiscal year 2019. The conference call will be held in English.
GHP Announces the Manufacturing and Packaging Awards 2019 Winners
AZP-3404, an optimized peptide derived from IGFBP-2, improves glucose control in a preclinical model of severe insulin resistance through a new and unique mechanism of action
The Society for Clinical Research Sites announced to attendees at its 2019 European Site Solutions Summit that SCALA Clinical Research is the winner of the European Site Patient Recruitment Innovation Award.
Recipharm has announced that its 2018 International Environmental Award will be presented to Dr. Bryan Brooks, Distinguished Professor in Environmental Science and Biomedical Studies at Baylor University in Waco, Texas.
Topas Therapeutics GmbH, a Hamburg, Germany-based private platform company leveraging the natural tolerance induction capabilities of the liver, announced that the Company will participate at several conferences this spring.
PRESS RELEASES